Serina Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Serina Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2017 to Q2 2024.
  • Serina Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 8.79M shares, a 76.8% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 8.79M -29.2M -76.8% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 8.41M -29.5M -77.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 2.41M +1.33M +123% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 38M +3.85K +0.01% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 38M +6.15K +0.02% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 38M +8.2K +0.02% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 1.08M -36.9M -97.2% Dec 31, 2022 10-K 2024-03-22
Q3 2022 37.9M +7.98K +0.02% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 37.9M +7.98K +0.02% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 37.9M +8.06K +0.02% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 37.9M +250K +0.66% Dec 31, 2021 10-K 2023-03-31
Q3 2021 37.9M +250K +0.66% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 37.9M +279K +0.74% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 37.9M +279K +0.74% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 37.7M +42K +0.11% Dec 31, 2020 10-K 2022-03-29
Q3 2020 37.7M +40K +0.11% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 37.7M +28K +0.07% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 37.7M +26K +0.07% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 37.6M +1.82M +5.08% Dec 31, 2019 10-K 2021-03-31
Q3 2019 37.6M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 37.6M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 37.6M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 35.8M +2.08M +6.16% Dec 31, 2018 10-K/A 2020-03-31
Q4 2017 33.8M Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.